OPENINTRO:STATISTICS
OPENINTRO:STATISTICS
4th Edition
ISBN: 9781943450077
Author: OPENINTRO
Publisher: amazon.com
bartleby

Concept explainers

bartleby

Videos

Question
Book Icon
Chapter 2.3, Problem 25E

(a)

To determine

Delineate the statement as true or false.

Explain the reasoning, if the statement is identified as false.

(b)

To determine

Obtain the proportion of all patients who have cardiovascular diseases.

(c)

To determine

Find the number of patients in the rosiglitazone group who would be expected to have had cardiovascular problems.

(d)

To determine

i. State the claim being tested.

ii. Identify the group that would provide more support from the alternative hypothesis, more or fewer patients with cardiovascular problems in the rosiglitazone group.

iii. Discuss the suggestion provided by the simulation results about the relationship between taking rosiglitazone and having cardiovascular problems in diabetic patients.

Blurred answer
Students have asked these similar questions
Tan/ page Rosiglitazone is the active ingredient in the controversial type 2 diabetes medicine Avandia and has been linked to an increased risk of serious cardiovascular problems such as stroke, heart failure, and death. A common alternative treatment is pioglitazone, the active ingredient in a diabetes medicine called Actos. In a nationwide retrospective observational study of 227,571 Medicare beneficiaries aged 65 years or older, it was found that 2,593 of the 67,593 patients using rosiglitazone and 5,386 of the 159,978 using pioglitazone had serious cardiovascular problems. These data are summarized in the contingency table below. Cardiovascular problems Yes No Total Rosiglitazone 2,593 65,000 Pioglitazone 5,386 154,592 159,978 67,593 Total 7,979 219,592 227,571 a) Write a set of hypotheses comparing the rates for cardiovascular problems for the two treatments. Но: р, — рp? На: р, — Рp ? Compute the point estimate, the observed difference in rates for cardiovascular problems in the…
Side effects of Avandia - Rosiglitazone is the active ingredient in the controversial type 2 diabetes medicine Avandia and has been linked to an increased risk of serious cardiovascular problems such as stroke, heart failure, and death. A common alternative treatment is pioglitazone, the active ingredient in a diabetes medicine called Actos. In a nationwide retrospective observational study of 227,571 Medicare beneficiaries aged 65 years or older, it was found that 2,593 of the 67,593 patients using rosiglitazone and 5,386 of the 159,978 using pioglitazone had serious cardiovascular problems. The data is summarized in the contingency table below. Cardiovascular problems Yes No Total Rosiglitazone 2,593 65,000 67,593 Pioglitazone 5,386 154,592 159,978 Total 7,979 219,592 227,571 1. What proportion of all patients had cardiovascular problems? Round your answer to four decimal places. 2. What is the difference in proportion of patients with cardiovascular problems between the…
Rosiglitazone is the active ingredient in the controversial type 2 diabetes medicine Avandia and has been linked to an increased risk of serious cardiovascular problems such as stroke, heart failure, and death. A common alternative treatment is pioglitazone, the active ingredient in a diabetes medicine called Actos. In a nationwide retrospective observational study of 22,757 Medicare beneficiaries aged 65 years or older, it was found that 259 of the 6,759 patients using rosiglitazone and 539 of the 15,998 using pioglitazone had serious cardiovascular problems. These data are summarized in the contingency table below. Rosiglitazone Pioglitazone Total Cardiovascular problems Yes No 259 539 a) Write a set of hypotheses comparing the rates for cardiovascular problems for the two treatments. Ho: Pr-Pp ? 8 HA: P-Pp? B Total 6,500 6,759 15,459 15,998 798 21,959 22,757 b) Compute the point estimate, the observed difference in rates for cardiovascular problems in the two treatments. Pr-Pp= c)…
Knowledge Booster
Background pattern image
Statistics
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, statistics and related others by exploring similar questions and additional content below.
Similar questions
SEE MORE QUESTIONS
Recommended textbooks for you
Text book image
MATLAB: An Introduction with Applications
Statistics
ISBN:9781119256830
Author:Amos Gilat
Publisher:John Wiley & Sons Inc
Text book image
Probability and Statistics for Engineering and th...
Statistics
ISBN:9781305251809
Author:Jay L. Devore
Publisher:Cengage Learning
Text book image
Statistics for The Behavioral Sciences (MindTap C...
Statistics
ISBN:9781305504912
Author:Frederick J Gravetter, Larry B. Wallnau
Publisher:Cengage Learning
Text book image
Elementary Statistics: Picturing the World (7th E...
Statistics
ISBN:9780134683416
Author:Ron Larson, Betsy Farber
Publisher:PEARSON
Text book image
The Basic Practice of Statistics
Statistics
ISBN:9781319042578
Author:David S. Moore, William I. Notz, Michael A. Fligner
Publisher:W. H. Freeman
Text book image
Introduction to the Practice of Statistics
Statistics
ISBN:9781319013387
Author:David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:W. H. Freeman
Statistics 4.1 Point Estimators; Author: Dr. Jack L. Jackson II;https://www.youtube.com/watch?v=2MrI0J8XCEE;License: Standard YouTube License, CC-BY
Statistics 101: Point Estimators; Author: Brandon Foltz;https://www.youtube.com/watch?v=4v41z3HwLaM;License: Standard YouTube License, CC-BY
Central limit theorem; Author: 365 Data Science;https://www.youtube.com/watch?v=b5xQmk9veZ4;License: Standard YouTube License, CC-BY
Point Estimate Definition & Example; Author: Prof. Essa;https://www.youtube.com/watch?v=OTVwtvQmSn0;License: Standard Youtube License
Point Estimation; Author: Vamsidhar Ambatipudi;https://www.youtube.com/watch?v=flqhlM2bZWc;License: Standard Youtube License